Nepal, Aug. 13 -- Nepal is set to receive 13,200 vials of anti-snake venom (ASV) this week as the government moves to ensure uninterrupted treatment amid concerns over a shortage of the lifesaving medicine.

The Epidemiology and Disease Control Division (EDCD) said 2,400 vials of ASV are currently in stock across the country, enough to meet demand for the next few weeks.

Dr Amrit Pokharel, chief of the EDCD's outbreak management section, said 800 of the 2,400 vials have been reserved for the Tarai region. He said the existing stock is expected to last for several weeks, while preparations are underway to procure additional supplies from India within a week.

Dr Sanjib Kumar Sharma, a snakebite expert at B.P. Koirala Institute of Health ...